| Alzheimer |
| Brain diseases |
| Research |
| Tau |
| APP |
| Abeta |
| VCDN group |
 |
| ALS/PDC Guam |
| AGD |
| Bri |
| CBD |
|
DLDH |
| DM1 |
| Down S |
| GSS |
| FTD |
| FTDP-17 |
| Huntington |
| Hallenvorden |
| IBM |
| Lewy BD |
| MSA |
| NPiD c |
| Parkinson D Guadeloupe |
| Parkinson |
| Dementia in Parkinson |
| Pick |
| Prion |
| PSP |
| PEP |
| Semantic D |
|
SSP |
| ToD |
Publications 1995
1995-1) BONS N., JALLAGEAS V., MESTRE-FRANCES N., SILHOL S., PETTER A.,
DELACOURTE A. Microcebus murinus, a convenient laboratory animal model
for the study of Alzheimer's disease. Alzheimer's research, 1995;
1:83-87.
1995-2) BONS N., JALLAGEAS V., SILHOL S., MESTRE-FRANCES N., PETTER A.,
DELACOURTE A. Immunocytochemical characterization of Tau proteins during
cerebral aging of the lemurian primate Microcebus murinus. C.R.Acad.Sci.
Paris, 1995; 318:77-83.
1995-3)
BUÉE L., PERMANNE B., PÉREZ-TUR J., CHARTIER-HARLIN M-C.,
DELACOURTE A. Alzheimer's disease: Aß or ApoE amyloidosis ? The
Lancet 1995,346:59.
1995-4) BUEE-SCHERRER V., BUEE L., HOF P.R, LEVEUGLE B., GILLES C.,
LOERZEL A.J, PERL D.P, DELACOURTE A. Neurofibrillary degeneration in Amyotrophic
Lateral Sclerosis / Parkinsonism- Dementia complex of Guam: immunochemical
characterization of tau proteins. Am. J. Pathology. 1995, 68: 924-932.
1995-5) BUEE-SCHERRER, V., BUEE, L.; HOF, P.R.; VERMERSCH, P.; LEVEUGLE,
B.; WATTEZ, A.; BOURAS, C.; PERL, D.P.; DELACOURTE, A. Tau variants in
Aging and neurodegenerative disorders. In Kosik, K., Selkoe, D.J., Christen,
Y (eds). Alzheimer's disease: lessons from cell biology. Research and
Perspectives in Alzheimer's Disease. Springer Verlag, Berlin,
Heidelberg. 1995 ; 132-149.
1995-6) CONDAMINES O., BUÉE-SCHERRER V., BOISSIER L., WATTEZ A.,
DELACOURTE A., PAU B., MOURTON-GILLES C. New immunoassay for the mapping
of neurofibrillary degeneration in Alzheimer's disease using two monoclonal
antibodies against human PHF-tau proteins. Neurosciences Letters.
1995.192:1-4.
1995-7) DELACOURTE A, SAUTIERE P-E , WATTEZ A, GILLES-MOURTON C, PETTER
A, BONS. Biochemical characterization of Tau proteins during cerebral
aging of the lemurian primate Microcebus murinus. C.R.Acad.Sci. Paris.
1995; 318:85-89.
1995-8) DUPONT-WALLOIS
L., SAUTIERE P.E., COCQUERELLE C., BAILLEUL B., DELACOURTE A., CAILLET-BOUDIN
ML. Shift from foetal-type to Alzheimer-type phosphorylated Tau proteins
in SKNSH-SY 5Y cells treated by Okadaic acid. FEBS Letters, 1995
357:197-201.
1995-9) ELHADDAOUI A., PIGORSCH E., DELACOURTE A., TURRELL S. Spectroscopic
investigations of synthetic beta amyloid peptides of Alzheimer's disease.
J. Mol. Structure. 1995 347; 363-370.
1995) LEVEUGLE B., DING W., BUÉE L., FILLIT H. Interleukin-I and
nerve growth factor induce hypersecretion and hypersulfation of neuroblastoma
proteoglycans which bind beta-amyloid. Neuroimmunol. 1995, 60:151-160.
1995-10) PÉREZ-TUR D., CAMPION D., MARTINEZ M., BRICE A., TARDIEU
S., HANNEQUIN D., AGID Y., DELACOURTE A., CLERGET-DARPOUX F., CHARTIER-HARLIN
M-C. and the French Alzheimer's Disease Collaborative Study Group. Evidence
for ApoE E4 association in early-onset Alzheimer's disease population
with late-onset relatives. Am J Med Genet. 1995;60:550-553.
1995-11)
PERMANNE B., BUÉE L., DAVID J-P., FALLET-BIANCO C., DI MENZA C.,
DELACOURTE A. Quantitation of Alzheimer's amyloid peptide and identification
of related amyloid proteins by dot-blot immunoassay. Brain Research.
685:154-162.
1995-12) REIG S., BUEE-SCHERRER V., MOURTON-GILLES., DEFOSSEZ A.,
DELACOURTE, A., BEAUVILLAIN J-C., MAZZUCA, M. Immunogold labelling of
Paired Helical Filaments and amyloid filaments by specific monoclonal
and polyclonal antibodies. Acta Neuropathol. 90: 441-447.
1995-13) SERGEANT
N, BUSSIERE T, VERMERSCH P, LEJEUNE J.P, DELACOURTE A. Isoelectric point
differentiates PHF-tau from biopsy-derived human brain Tau proteins. Neuroreport.
1995, 6: 2217-2220.
1995-14) VERMERSCH P., BORDER R., LEDOZE F., RUCHOUX M-M, CHAPON F.,
THOMAS P., DESTEE A., LECHEVALLIER B., DELACOURTE, A. Demonstration of
a specific profile of pathological Tau proteins in FrontoTemporal dementia
cases. C. R. Acad. Sci Paris. 1995, 318:439-445.
1995-15) VERMERSCH
P., DAVID J-P FRIGARD B., FALLET-BIANCO C., WATTEZ A., PETIT H., DELACOURTE
A. Cortical mapping of Alzheimer pathology in brains of aged non-demented
subjects. Prog. Neuropsychopharmaco. & Biol Psychiatry. 1995;
19:1035-1047.
Autres publications:
1995-16) BUEE L., PERMANNE B., DAVID J-P., DELACOURTE A. Combien de mg
d'amyloïde dans l'Alzheimer? Alzheimer actualités,
1995, 96, 6-11.
1995-17) CHARTIER-HARLIN, M.C., PÉREZ-TUR, J. Apolipoprotéine
E: une protéine aux multiples facettes. Alzheimer Actualités,
96, 6-11.
1995-18) DELACOURTE A. La Maladie d'Alzheimer: de l'analyse biochimique
des lésions aux perspectives thérapeutiques. Alpha Med,
1995,4:56-61.
1995-19) DELACOURTE A AND VERMERSCH P. Cytoskeleton defects in Neurons.
Sandoz Lectures in Gerontology 1995 Adaptations in Aging, 1995,
Academic Press LTD, 187-202.
1995-20) DELACOURTE A., ROBITAILLE Y., SERGEANT N., WATTEZ A., LAROCHE-CHOLETT
A., MATHIEU J., GRENON M., CHAGNON P., GAUVREAU D. Specific patterns of
Tau protein isoforms are expressed in Pick's Disease. J. Neuropathl.
Exp. Neurol. 1995;54:447.
1995-21) Pasquier F, Lebert F, Ruchoux MM, Vermersch P, Delacourte A.
Neuropathologie. dans Les démences fronto-temporales édité
par Pasquier F et Lebert F. Masson . 1995. 35-62.
1995-22) Pasquier F, Lebert F, Chartier-Harlin MC. Génétique
dans Les démences fronto-temporales édité par Pasquier
F et Lebert F. Masson . 1995. 31-35.
1995-23) PÉREZ-TUR, J., WAVRANT-DE VRIEZE, F., CHARTIER-HARLIN,
M.-C., La génétique de la maladie d'Alzheimer. 8ème
série des Actualités en Pharmacie et Biologie Medicale.